China cooperates with the US on stem-cell treatment of corneal diseases

The partners involved are the Zhongshan Ophtalmic Center, Liu YI, and the Human Genome Research Institute, San Diego, Kang ZHANG. The focus is on the regulation of limbal stem cell differentiation and PAX6 WNT7A as a key factor in corneal lineage differentiation.

China Bio news release, July 9, 2014

Most popular posts: